121 related articles for article (PubMed ID: 8713111)
1. Ligand-induced dimerization of the extracellular domain of the TGF-beta receptor type II.
Letourneur O; Goetschy JF; Horisberger M; Grütter MG
Biochem Biophys Res Commun; 1996 Jul; 224(3):709-16. PubMed ID: 8713111
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta receptor expression on human skin fibroblasts: dimeric complex formation of type I and type II receptors and identification of glycosyl phosphatidylinositol-anchored transforming growth factor-beta binding proteins.
Tam BY; Philip A
J Cell Physiol; 1998 Sep; 176(3):553-64. PubMed ID: 9699508
[TBL] [Abstract][Full Text] [Related]
3. Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent.
Zúñiga JE; Groppe JC; Cui Y; Hinck CS; Contreras-Shannon V; Pakhomova ON; Yang J; Tang Y; Mendoza V; López-Casillas F; Sun L; Hinck AP
J Mol Biol; 2005 Dec; 354(5):1052-68. PubMed ID: 16289576
[TBL] [Abstract][Full Text] [Related]
4. Fermentable metabolite of Zymomonas mobilis controls collagen reduction in photoaging skin by improving TGF-beta/Smad signaling suppression.
Tanaka H; Yamaba H; Kosugi N; Mizutani H; Nakata S
Arch Dermatol Res; 2008 Apr; 300 Suppl 1():S57-64. PubMed ID: 18060420
[TBL] [Abstract][Full Text] [Related]
5. Rap1 reverses transcriptional repression of TGF-beta type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1.
Fralix KD; Zhao S; Venkatasubbarao K; Freeman JW
J Cell Physiol; 2003 Jan; 194(1):88-99. PubMed ID: 12447993
[TBL] [Abstract][Full Text] [Related]
6. The GS domain of the transforming growth factor-beta type I receptor is important in signal transduction.
Franzén P; Heldin CH; Miyazono K
Biochem Biophys Res Commun; 1995 Feb; 207(2):682-9. PubMed ID: 7864860
[TBL] [Abstract][Full Text] [Related]
7. Concurrent and distinct transcription and translation of transforming growth factor-beta type I and type II receptors in rodent embryogenesis.
Mariano JM; Montuenga LM; Prentice MA; Cuttitta F; Jakowlew SB
Int J Dev Biol; 1998 Nov; 42(8):1125-36. PubMed ID: 9879710
[TBL] [Abstract][Full Text] [Related]
8. Alternative splicing of TGF-betas and their high-affinity receptors T beta RI, T beta RII and T beta RIII (betaglycan) reveal new variants in human prostatic cells.
Konrad L; Scheiber JA; Völck-Badouin E; Keilani MM; Laible L; Brandt H; Schmidt A; Aumüller G; Hofmann R
BMC Genomics; 2007 Sep; 8():318. PubMed ID: 17845732
[TBL] [Abstract][Full Text] [Related]
9. Expression of recombinant human soluble type II transforming growth factor-beta receptor in Pichia pastoris and Escherichia coli: two powerful systems to express a potent inhibitor of transforming growth factor-beta.
Glansbeek HL; van Beuningen HM; Vitters EL; van der Kraan PM; van den Berg WB
Protein Expr Purif; 1998 Mar; 12(2):201-7. PubMed ID: 9518461
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.
Bierie B; Stover DG; Abel TW; Chytil A; Gorska AE; Aakre M; Forrester E; Yang L; Wagner KU; Moses HL
Cancer Res; 2008 Mar; 68(6):1809-19. PubMed ID: 18339861
[TBL] [Abstract][Full Text] [Related]
11. Signal transduction by transforming growth factor-beta: a cooperative paradigm with extensive negative regulation.
Engel ME; Datta PK; Moses HL
J Cell Biochem Suppl; 1998; 30-31():111-22. PubMed ID: 9893262
[TBL] [Abstract][Full Text] [Related]
12. Mouse embryonic stem cells with aberrant transforming growth factor beta signalling exhibit impaired differentiation in vitro and in vivo.
Goumans MJ; Ward-van Oostwaard D; Wianny F; Savatier P; Zwijsen A; Mummery C
Differentiation; 1998 Jul; 63(3):101-13. PubMed ID: 9697304
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the human TbetaR2 ectodomain--TGF-beta3 complex.
Hart PJ; Deep S; Taylor AB; Shu Z; Hinck CS; Hinck AP
Nat Struct Biol; 2002 Mar; 9(3):203-8. PubMed ID: 11850637
[TBL] [Abstract][Full Text] [Related]
14. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK
Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532
[TBL] [Abstract][Full Text] [Related]
15. Truncation of the TGF-beta type II receptor gene results in insensitivity to TGF-beta in human gastric cancer cells.
Yang HK; Kang SH; Kim YS; Won K; Bang YJ; Kim SJ
Oncogene; 1999 Apr; 18(13):2213-9. PubMed ID: 10327067
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells.
Miyafuji Y; Zhong X; Uchida I; Koi M; Hemmi H
J Cell Physiol; 2001 Jun; 187(3):356-64. PubMed ID: 11319759
[TBL] [Abstract][Full Text] [Related]
17. Interaction of transforming growth factor beta receptors with apolipoprotein J/clusterin.
Reddy KB; Karode MC; Harmony AK; Howe PH
Biochemistry; 1996 Jan; 35(1):309-14. PubMed ID: 8555189
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta receptors: structure and function.
Lin HY; Moustakas A
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):337-49. PubMed ID: 7920178
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation.
Jakowlew SB; Moody TW; Mariano JM
Anticancer Res; 1997; 17(3C):1849-60. PubMed ID: 9216635
[TBL] [Abstract][Full Text] [Related]
20. Cooperative binding of transforming growth factor (TGF)-beta 2 to the types I and II TGF-beta receptors.
Rodriguez C; Chen F; Weinberg RA; Lodish HF
J Biol Chem; 1995 Jul; 270(27):15919-22. PubMed ID: 7608141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
